<Originals>Effects of partial hepatectomy, phenobarbital and buthionine sulfoximine on rat hepatocytes positive for the placental form of aflatoxin B_1-induced glutathione transferase
スポンサーリンク
概要
- 論文の詳細を見る
Biochemical studies have indicated that glutathione (GSH) and glutathione-S-transferases (GSTs) play an important role in modulating hepatic aflatoxin B_1 (AFB_1)-DNA binding and AFB_1 hepatocarcinogenesis in the rat. The presence of GST-placental (GST-P) form positive hepatocytes is considered to be an early marker for initiation during the hepatocarcinogenesis. The effects of partial hepatectomy, phenobarbital (PB) and buthionine sulfoximine (BSO) pretreatments of rats have been examined on AFB_1-induced GST-P positive single hepatocytes using a single dose carcinogen model. Young male Fischer rats fed a commericial diet with or without 0.1% PB in their drinking water for 1 wk were used for these studies. Some rats were partially hepatectomized 18-20 hr before AFB_1 administration whereas some rats were injected with 4 mmol BSO/kg body wt 4 hr and 2 hr before intraperitoneal (i.p.) injection of AFB_1. Most animals were injected i.p. with AFB_1 whereas some animals were injected i.p. with DMSO alone. Livers of all rats sacrificed 48 hr or 144 hr after DMSO or AFB_1 treatment were fixed for immunohistochemical demonstration of GST-P positive hepatocytes. Partial hepatectomy before AFB_1 (0.5-4.0 mg/kg body wt) injection yielded 2-3 times as many GST-P positive single hepatocytes/sq.cm. as sham operated rats 48 hr after AFB_1 injection. Control, PB- or BSO-pretreated rats without AFB_1 injection produced a small number of about 0.3/sq. cm. GST-P positive hepatocytes whereas control and PB-treated rats after AFB_1 (2 mg/kg body wt) treatment yielded about 10.1 and 2.8 GST-P positive hepatocytes/sq. cm. respectively. Pretreatment of these two groups with BSO before AFB_1 injection increased the yield of GST-P positive hepatocytes by 145% and 180% above their respective controls. Similar data were obtained when rats were sacrificed 144 hr after AFB_1 injection. In these studies, all rats pretreated with BSO died within 144 hr after AFB_1 injection. Pretreatment with PB inhibited AFB_1-induced GST-P positive hepatocytes by 90% control levels. Pretreatment with BSO of PB-treated rats increased the yield of AFB_1-induced GST-P positive hepatocytes by 580% PB-controls. A small number of AFB_1-induced GST-P positive minifoci (6-8) was also observed with PB and BSO pretreatment of rats. The overall data suggest that PB pretreatment of rats inhibits AFB_1-induced GST-P positive hepatocytes whereas BSO pretreatment of both control and PB-treated animals enhances AFB_1-induced GST-P positive hepatocytes. These results are in agreement with previous data indicating inhibition of hepatic AFB_1-DNA binding by PB treatment and increase of AFB_1-DNA binding by BSO pretreatment of rats. Thus, there appears to be positive correlation between hepatic AFB_1-DNA binding and AFB_1-induced GST-P positive hepatocytes. The present data strongly suggest that BSO pretreatment of rats may enhance AFB_1 hepatocarcinogenesis in the rat.
- 近畿大学の論文
著者
-
Horiuchi Atsushi
Third Department Of Internal Medicine Kinki University School Of Medicine
-
Tsuji Kojiro
Third Department Of Internai Medicine Kinki University Sohool Of Medicine : Fels Institute For Cance
-
LOTLIKAR Prabhakar
Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine
-
Horiuchi Atsushi
Third Department Of Internai Medicine Kinki University Sohool Of Medicine
-
Lotlikar Prabhakar
Fels Institute For Cancer Research And Molecular Biology Temple University School Of Medicine
関連論文
- Azole resistant Candida albicans in a leukemic patient : a case report
- Clinical differences between hypoplastic and normocellular or hyperplastic myelodysplastic syndrome
- Comparative effects of three nitrosourea derivatives on cell cycle kinetics
- Prognostic significance of bone marrow lymphocyte counts in the nadir phase of acute myelocytic leukemia
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Interferon-γ modulate Ia antigen expression on thymic reticuloepithelial cells in New Zealand mice
- Change of serum erythropoietin levels after allogeneic bone marrow transplantation
- Changes in M-CSF activity and CFU-GM- Inhibitory activity in the urine of patient with cyclic chronic myelogenous leukemia
- Combined Efficacy of Fosfomycin and Sulbactam/Cafoperazone in Opportunistic Infections in Patients with Hematologic Disorders-A Randomized Comparative Study of Antibiotic Efficacy Based on the Order of Sequential Administration
- Improved Survival in Patients with Multiple Myeloma Treated with DMVM plus IFN-α
- Residual Renal Function and Urinary Excretion Substrate by Loop Diuretics Infusion Test in the Patients with Renal Failure
- Characteristics of the Clinical Findings in Patients with Idiopathic Thrombocytopenic Purpura Who are Positive for Anti-phospholipid Antibodies
- Effects of partial hepatectomy, phenobarbital and buthionine sulfoximine on rat hepatocytes positive for the placental form of aflatoxin B_1-induced glutathione transferase
- Measurement of DNA-anti-DNA immune complexes in an antigen specific manner
- Effect of Immunoadsorption Therapy in Systemic Lupus Erythematosus(Collagen Disease,General Presentation)